Diabetes rates surge 18.6% in the U.S., highlighting racial and economic disparities

Researchers evaluate national trends and disparities in the prevalence of diabetes among adults in the United States.

Cybin’s Leap Forward: DMT-Based Therapy Ready for Phase 2 Trials

The TDR Three Key Takeaways Innovative DMT-Based Therapies: Cybin Inc. is evolving psychedelic therapy with CYB004 and SPL028, derived from DMT. These therapies are significant

January 8, 2024

What’s really in your kombucha and kefir?

Researchers have delved into the bacterial diversity of 47 different fermented foods, revealing significant variations in microbial richness and composition. The study highlights that foods

October 25, 2023

Sandoz unveils biosimilar Hyrimoz HCF in Europe

Share this article The updated formulation will facilitate a reduction in injection volume by 50%. Credit: unoL / shutterstock.com. Sandoz has unveiled its Hyrimoz (adalimumab)

November 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.